scholarly journals Mitochondrial stress response triggered by defects in protein synthesis quality control

2019 ◽  
Vol 2 (1) ◽  
pp. e201800219 ◽  
Author(s):  
Uwe Richter ◽  
Kah Ying Ng ◽  
Fumi Suomi ◽  
Paula Marttinen ◽  
Taina Turunen ◽  
...  
Keyword(s):  
Quality Control ◽  
Protein Synthesis ◽  
Stress Response ◽  
Expression System ◽  
Mitochondrial Protein ◽  
Clinical Syndrome ◽  
Control Mechanisms ◽  
Mitochondrial Protein Synthesis ◽  
Mitochondrial Ribosomes ◽  
Form And Function

Mitochondria have a compartmentalized gene expression system dedicated to the synthesis of membrane proteins essential for oxidative phosphorylation. Responsive quality control mechanisms are needed to ensure that aberrant protein synthesis does not disrupt mitochondrial function. Pathogenic mutations that impede the function of the mitochondrial matrix quality control protease complex composed of AFG3L2 and paraplegin cause a multifaceted clinical syndrome. At the cell and molecular level, defects to this quality control complex are defined by impairment to mitochondrial form and function. Here, we establish the etiology of these phenotypes. We show how disruptions to the quality control of mitochondrial protein synthesis trigger a sequential stress response characterized first by OMA1 activation followed by loss of mitochondrial ribosomes and by remodelling of mitochondrial inner membrane ultrastructure. Inhibiting mitochondrial protein synthesis with chloramphenicol completely blocks this stress response. Together, our data establish a mechanism linking major cell biological phenotypes of AFG3L2 pathogenesis and show how modulation of mitochondrial protein synthesis can exert a beneficial effect on organelle homeostasis.

scholarly journals Translation of MT-ATP6 pathogenic variants reveals distinct regulatory consequences from the co-translational quality control of mitochondrial protein synthesis.

2021 ◽  
Author(s):  
Kah Ying Ng ◽  
Uwe Richter ◽  
Christopher Jackson ◽  
Sara Seneca ◽  
Brendan Battersby
Keyword(s):  
Quality Control ◽  
Protein Synthesis ◽  
Mitochondrial Gene ◽  
Mitochondrial Protein ◽  
Control Mechanisms ◽  
Mitochondrial Protein Synthesis ◽  
Primary Defect ◽  
Pathogenic Variants ◽  
Heterogenous Group ◽  
Quality Control Mechanism

Pathogenic variants that disrupt human mitochondrial protein synthesis are associated with a clinically heterogenous group of diseases. Despite an impairment in oxidative phosphorylation being a common phenotype, the underlying molecular pathogenesis is more complex than simply a bioenergetic deficiency. Currently, we have limited mechanistic understanding on the scope by which a primary defect in mitochondrial protein synthesis contributes to organelle dysfunction. Since the proteins encoded in the mitochondrial genome are hydrophobic and need co-translational insertion into a lipid bilayer, responsive quality control mechanisms are required to resolve aberrations that arise with the synthesis of truncated and misfolded proteins. Here, we show that defects in the OXA1L-mediated insertion of MT-ATP6 nascent chains into the mitochondrial inner membrane are rapidly resolved by the AFG3L2 protease complex. Using pathogenic MT-ATP6 variants, we then reveal discrete steps in this quality control mechanism and the differential functional consequences to mitochondrial gene expression. The inherent ability of a given cell type to recognize and resolve impairments in mitochondrial protein synthesis may in part contribute at the molecular level to the wide clinical spectrum of these disorders.

Decreased total ventricular and mitochondrial protein synthesis during extended anoxia in turtle heart

1996 ◽  
Vol 271 (6) ◽  
pp. R1660-R1667 ◽  
Author(s):  
J. R. Bailey ◽  
W. R. Driedzic
Keyword(s):  
Protein Synthesis ◽  
Energy Levels ◽  
Mitochondrial Protein ◽  
Atp Synthesis ◽  
Cellular Protein ◽  
Control Mechanisms ◽  
Mitochondrial Protein Synthesis ◽  
Available Energy ◽  
Pressure Development ◽  
Turtle Heart

The turtle heart provides a model system to study the effects of anoxia on protein synthesis without the potentially confounding factor of contractile failure and decreased ATP levels. Protein synthesis, as measured by 3H-labeled phenylalanine incorporation, was studied under conditions of normoxia and anoxia in isolated perfused turtle [Trachemys (= Pseudemys) scripta elegans] hearts at 15 degrees C. Heart rate, cardiac output, and ventricular pressure development were unaffected by 2 or 3 h of anoxia. Despite the anoxia, energy levels in the heart were presumably still high, since contractility was maintained. RNA content of ventricle decreased after anoxic perfusion. Rates of total protein synthesis rates in ventricle were threefold lower under anoxia than under normoxia. These findings suggest that the total level of RNA is one determinant of protein synthesis. Incorporation of label into protein extracted from mitochondria was also assessed. The ratio of mitochondrial to whole ventricular protein synthesis was significantly lower after anoxia, revealing preferential control mechanisms under anoxia between the synthesis of total cellular protein and protein destined for mitochondria. Isolated mitochondria were still coupled after 2 or 3 h of anoxia. In effect, the mitochondria enter into a state of hypometabolism in terms of rates of ATP synthesis and protein synthesis, but functional integrity is maintained. The decrease in protein synthesis in general and mitochondrial protein synthesis in particular may represent an adaptation to allow the partitioning of the available energy resources toward mechanical function during anoxia.

scholarly journals Quality control of mitochondrial protein synthesis is required for membrane integrity and cell fitness

2015 ◽  
Vol 211 (2) ◽  
pp. 373-389 ◽  
Author(s):  
Uwe Richter ◽  
Taina Lahtinen ◽  
Paula Marttinen ◽  
Fumi Suomi ◽  
Brendan J. Battersby
Keyword(s):  
Quality Control ◽  
Protein Synthesis ◽  
Oxidative Phosphorylation ◽  
De Novo ◽  
Mitochondrial Protein ◽  
Membrane Integrity ◽  
Mitochondrial Proteins ◽  
Protein Accumulation ◽  
Mitochondrial Protein Synthesis ◽  
Inner Membrane

Mitochondrial ribosomes synthesize a subset of hydrophobic proteins required for assembly of the oxidative phosphorylation complexes. This process requires temporal and spatial coordination and regulation, so quality control of mitochondrial protein synthesis is paramount to maintain proteostasis. We show how impaired turnover of de novo mitochondrial proteins leads to aberrant protein accumulation in the mitochondrial inner membrane. This creates a stress in the inner membrane that progressively dissipates the mitochondrial membrane potential, which in turn stalls mitochondrial protein synthesis and fragments the mitochondrial network. The mitochondrial m-AAA protease subunit AFG3L2 is critical to this surveillance mechanism that we propose acts as a sensor to couple the synthesis of mitochondrial proteins with organelle fitness, thus ensuring coordinated assembly of the oxidative phosphorylation complexes from two sets of ribosomes.

scholarly journals Human GTPBP5 (MTG2) fuels mitoribosome large subunit maturation by facilitating 16S rRNA methylation

2020 ◽  
Vol 48 (14) ◽  
pp. 7924-7943 ◽  
Author(s):  
Priyanka Maiti ◽  
Hana Antonicka ◽  
Anne-Claude Gingras ◽  
Eric A Shoubridge ◽  
Antoni Barrientos
Keyword(s):  
Quality Control ◽  
16S Rrna ◽  
Large Subunit ◽  
Mitochondrial Protein ◽  
Small Gtpases ◽  
Mitochondrial Protein Synthesis ◽  
Mitochondrial Ribosomes ◽  
Family Protein ◽  
Assembly Factors ◽  
Subunit Joining

Abstract Biogenesis of mammalian mitochondrial ribosomes (mitoribosomes) involves several conserved small GTPases. Here, we report that the Obg family protein GTPBP5 or MTG2 is a mitochondrial protein whose absence in a TALEN-induced HEK293T knockout (KO) cell line leads to severely decreased levels of the 55S monosome and attenuated mitochondrial protein synthesis. We show that a fraction of GTPBP5 co-sediments with the large mitoribosome subunit (mtLSU), and crosslinks specifically with the 16S rRNA, and several mtLSU proteins and assembly factors. Notably, the latter group includes MTERF4, involved in monosome assembly, and MRM2, the methyltransferase that catalyzes the modification of the 16S mt-rRNA A-loop U1369 residue. The GTPBP5 interaction with MRM2 was also detected using the proximity-dependent biotinylation (BioID) assay. In GTPBP5-KO mitochondria, the mtLSU lacks bL36m, accumulates an excess of the assembly factors MTG1, GTPBP10, MALSU1 and MTERF4, and contains hypomethylated 16S rRNA. We propose that GTPBP5 primarily fuels proper mtLSU maturation by securing efficient methylation of two 16S rRNA residues, and ultimately serves to coordinate subunit joining through the release of late-stage mtLSU assembly factors. In this way, GTPBP5 provides an ultimate quality control checkpoint function during mtLSU assembly that minimizes premature subunit joining to ensure the assembly of the mature 55S monosome.

scholarly journals Mito-FUNCAT-FACS reveals cellular heterogeneity in mitochondrial translation

2022 ◽  
Author(s):  
Yusuke Kimura ◽  
Hironori Saito ◽  
Tatsuya Osaki ◽  
Yasuhiro Ikegami ◽  
Taisei Wakigawa ◽  
...  
Keyword(s):  
Protein Synthesis ◽  
Click Reaction ◽  
Mitochondrial Protein ◽  
Cell Types ◽  
Growth Conditions ◽  
Cellular Heterogeneity ◽  
Metabolic Labeling ◽  
Mitochondrial Protein Synthesis ◽  
Mitochondrial Translation ◽  
Mitochondrial Ribosomes

Mitochondria possess their own genome that encodes components of oxidative phosphorylation (OXPHOS) complexes, and mitochondrial ribosomes within the organelle translate the mRNAs expressed from mitochondrial genome. Given the differential OXPHOS activity observed in diverse cell types, cell growth conditions, and other circumstances, cellular heterogeneity in mitochondrial translation can be expected. Although individual protein products translated in mitochondria have been monitored, the lack of techniques that address the variation in overall mitochondrial protein synthesis in cell populations poses analytic challenges. Here, we adapted mitochondrial-specific fluorescent noncanonical amino acid tagging (FUNCAT) for use with fluorescence-activated cell sorting (FACS) and developed mito-FUNCAT-FACS. The click chemistry-compatible methionine analog L-homopropargylglycine (HPG) enabled the metabolic labeling of newly synthesized proteins. In the presence of cytosolic translation inhibitors, HPG was selectively incorporated into mitochondrial nascent proteins and conjugated to fluorophores via the click reaction (mito-FUNCAT). The application of in situ mito-FUNCAT to flow cytometry allowed us to disentangle changes in net mitochondrial translation activity from those of the organelle mass and detect variations in mitochondrial translation in cancer cells. Our approach provides a useful methodology for examining mitochondrial protein synthesis in individual cells.

scholarly journals Bovine mitochondrial protein synthesis elongation factors

1989 ◽  
Vol 264 (32) ◽  
pp. 19125-19131
Author(s):  
C J Schwartzbach ◽  
L L Spremulli
Keyword(s):  
Protein Synthesis ◽  
Mitochondrial Protein ◽  
Mitochondrial Protein Synthesis ◽  
Elongation Factors

scholarly journals Exploring the Ability of LARS2 Carboxy-Terminal Domain in Rescuing the MELAS Phenotype

Life ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. 674
Author(s):  
Francesco Capriglia ◽  
Francesca Rizzo ◽  
Giuseppe Petrosillo ◽  
Veronica Morea ◽  
Giulia d’Amati ◽  
...  
Keyword(s):  
Protein Synthesis ◽  
Molecular Mechanisms ◽  
Mitochondrial Protein ◽  
Trna Synthetase ◽  
Mitochondrial Protein Synthesis ◽  
Mitochondrial Translation ◽  
Terminal Domain ◽  
Carboxy Terminal Domain ◽  
Mitochondrial Functions ◽  
Carboxy Terminal

The m.3243A>G mutation within the mitochondrial mt-tRNALeu(UUR) gene is the most prevalent variant linked to mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome. This pathogenic mutation causes severe impairment of mitochondrial protein synthesis due to alterations of the mutated tRNA, such as reduced aminoacylation and a lack of post-transcriptional modification. In transmitochondrial cybrids, overexpression of human mitochondrial leucyl-tRNA synthetase (LARS2) has proven effective in rescuing the phenotype associated with m.3243A>G substitution. The rescuing activity resides in the carboxy-terminal domain (Cterm) of the enzyme; however, the precise molecular mechanisms underlying this process have not been fully elucidated. To deepen our knowledge on the rescuing mechanisms, we demonstrated the interactions of the Cterm with mutated mt-tRNALeu(UUR) and its precursor in MELAS cybrids. Further, the effect of Cterm expression on mitochondrial functions was evaluated. We found that Cterm ameliorates de novo mitochondrial protein synthesis, whilst it has no effect on mt-tRNALeu(UUR) steady-state levels and aminoacylation. Despite the complete recovery of cell viability and the increase in mitochondrial translation, Cterm-overexpressing cybrids were not able to recover bioenergetic competence. These data suggest that, in our MELAS cell model, the beneficial effect of Cterm may be mediated by factors that are independent of the mitochondrial bioenergetics.

Sign in / Sign up

Export Citation Format

Share Document